Integra LifeSciences Holdings Corporation (IART) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Integra LifeSciences Holdings Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.85x | -251.52x | 50.25x | 25.77x | 33.56x | 41.04x |
| P/B Ratio | 0.91x | 1.13x | 2.14x | 2.58x | 3.37x | 3.63x |
| P/S Ratio | 0.58x | 1.08x | 2.21x | 2.99x | 3.68x | 4.01x |
| Profitability | ||||||
| Gross Margin | 51.7% | 54.8% | 57.4% | 62.3% | 61.2% | 62.0% |
| Operating Margin | 4.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% |
| Net Margin | -31.6% | -0.4% | 4.4% | 11.6% | 11.0% | 9.8% |
| EBITDA Margin | -19.9% | 12.0% | 16.6% | 24.7% | 23.7% | 19.5% |
| Liquidity | ||||||
| Current Ratio | 2.54x | 1.17x | 3.45x | 3.62x | 3.39x | 3.09x |
| Quick Ratio | 1.46x | 0.71x | 2.18x | 2.61x | 2.46x | 2.31x |
| Leverage | ||||||
| Debt/Equity | 1.95x | 1.28x | 1.06x | 0.90x | 0.99x | 1.09x |
YoY = year-over-year change. Source: FMP..